Encompass Health Quarterly Cash Flow Statement
NYSE: EHCHealth CareHospital/Nursing ManagementUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Encompass Health free cash flow
In the quarter ended Jun 30, 2026, Encompass Health generated $282.6 million of operating cash flow and spent $220.3 million on capital expenditures. That left free cash flow of $62.3 million, a free-cash-flow margin of 3.9% of revenue. Free cash flow was down 45.0% from the prior year's $113.3 million.
Encompass Health returned $93.1 million to shareholders: $18.9 million in dividends and $74.2 million in share repurchases, equal to 149% of free cash flow. Free cash flow covered dividend payments 3.3 times.
Summary generated from market data by MetaCap's automated system. Methodology
Encompass Health cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 207.40M | 248.20M | 203.10M | 174.60M | 184.90M | 196.50M | 164.20M | 147.10M | 146.50M | 138.80M | 119.10M | 113.40M |
| Net Income growth (YoY) | +12.17% | +26.31% | +23.69% | +18.69% | +26.21% | +41.57% | +37.87% | +29.72% | +25.00% | +22.51% | +1.36% | +69.25% |
| Depreciation & Amortization | 90.40M | 87.30M | 86.40M | 82.40M | 79.90M | 79.20M | 78.00M | 78.40M | 72.90M | 70.30M | 70.10M | 67.30M |
| Stock-Based Compensation | 13.80M | 11.50M | 18.40M | 14.30M | 14.30M | 9.50M | 12.50M | 12.90M | 13.60M | 9.30M | 13.40M | 13.70M |
| Change in Working Capital | -27.10M | -33.80M | 300.00K | 11.20M | -3.90M | -7.50M | -25.40M | 54.30M | -11.80M | -1.60M | -53.00M | 12.50M |
| Operating Cash Flow | 282.60M | 313.10M | 346.00M | 270.80M | 270.20M | 288.60M | 278.80M | 267.80M | 217.40M | 238.80M | 201.00M | 215.20M |
| Capital Expenditures | -220.30M | -162.40M | -229.30M | -187.10M | -156.90M | -163.10M | -198.70M | -147.50M | -156.90M | -139.40M | -211.70M | -146.70M |
| Investing Cash Flow | -235.60M | -150.10M | -239.40M | -201.30M | -165.40M | -158.50M | -203.70M | -161.50M | -158.40M | -129.70M | -208.10M | -162.20M |
| Dividends Paid | -18.90M | -20.30M | -19.00M | -17.00M | -17.10M | -18.00M | -17.00M | -15.00M | -14.90M | -15.90M | -14.90M | -15.00M |
| Share Repurchases | -74.20M | -71.60M | -76.30M | -24.90M | -24.70M | -32.10M | -7.50M | -6.80M | -16.80M | 0 | 0 | 0 |
| Debt Repaid | — | — | -1.90M | -102.50M | — | — | -101.80M | -151.00M | -1.40M | -1.00M | -900.00K | -600.00K |
| Financing Cash Flow | -76.90M | -102.50M | -97.40M | -113.20M | -90.20M | -130.40M | -150.90M | -89.50M | -49.60M | -40.60M | -29.90M | -65.80M |
| Net Change in Cash | -29.90M | 60.50M | 9.20M | -43.70M | 14.60M | -300.00K | -75.80M | 16.80M | 9.40M | 68.50M | -37.00M | -12.80M |
| Free Cash Flow | 62.30M | 150.70M | 116.70M | 83.70M | 113.30M | 125.50M | 80.10M | 120.30M | 60.50M | 99.40M | -10.70M | 68.50M |
This table shows 12 quarterly periods of Encompass Health's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow EHC's reporting calendar. What is a cash flow statement?